Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

4 ETFs Set To Surge In Q4 Earnings

Published 01/14/2018, 10:57 PM
Updated 07/09/2023, 06:31 AM

The fourth-quarter earnings season is expected to be strong, with earnings growth likely to pick up and continue accelerating after dipping in the preceding quarter. The S&P 500 index is anticipated to see earnings growth of 9.2% and revenue growth of 7%. The market is also at record levels, scaling series of highs at the start of the year.

The forecast compares favorably with Q3 earnings growth of 6.7% on 5.9% revenue growth. The revision trend has been favorable with earnings estimates holding up better relative to other comparable periods. The earnings estimates for Q4 have moved up 2 percentage points from 8.6% at the start of the quarter. Additionally, 13 of the 16 Zacks sectors are likely to be contributors to earnings growth, suggesting potential upside in many corners of the market (read: 4 ETFs & Stocks from Favorite Sectors for Q4 Earnings).

Given the strong sentiments, investors should focus on ETFs with large allocations to stocks that have a high chance of surprising in their upcoming release. This could result in a winning bet this earnings season.

How to Find the Right ETFs?

Handpicking ETFs with a portfolio of stocks that are most likely to beat on earnings is no mean feat. However, our proprietary methodology of finding the Earnings ESP of stocks by calculating the percentage difference between the Most Accurate estimate and the Zacks Consensus Estimate is a solid building block.

You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Betting on ETFs with the winning combination of stocks that have a positive Earnings ESP and a favorable Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) would lead to profits for investors. This is especially true as an earnings beat will definitely draw investors’ attention and propel the stock price and related ETFs.

First, we ran our Zacks stock screener to find stocks with a positive Earnings ESP and a favorable Zacks Rank. Then, we narrowed down the list by selecting the group of stocks with higher positive Earnings ESP. Accordingly, we chose three ETFs, which comprise few stocks with higher chances of beating estimates in a particular industry (see: all the ETF Categories here).

Our research shows that for stocks with this combination, the chance of a positive earnings surprise is as high as 70%. As a result, these funds could be excellent for investors seeking guaranteed profits this earnings season.

VanEck Vectors Biotech ETF (LON:BBH)

This fund offers exposure to 26 large biotechnology corporations by tracking the MVIS US Listed Biotech 25 Index. About 34% of the stocks in the portfolio are expected to beat earnings this quarter. Amgen (NASDAQ:AMGN) , Celgene (NASDAQ:CELG) , Illumina (NASDAQ:ILMN) and Incyte (NASDAQ:INCY) are among the top 10 holdings, having an Earnings ESP of +1.45%, +1.46%, +1.96% and +53.15%, respectively. These firms have a Zacks Rank #3 and collectively account for 30.1% of assets. Biomarin Pharmaceutical (NASDAQ:BMRN) , which accounts for a 4.10% share in the basket, also has a Zacks Rank #3 and an Earnings ESP of +49.43%.

BBH has amassed $629.3 million in its asset base and charges 35 bps in fees per year. Volume is moderate as it exchanges 33,000 shares daily on average. It has a Zacks ETF Rank #3 with a High risk outlook (read: Value Biotech ETFs to Buy Now).

PowerShares Dynamic Retail Portfolio (V:PMR)

This fund follows the Dynamic Retail Intellidex Index, which measures the performance of companies engaged in operating general merchandise stores such as department stores, discount stores, warehouse clubs and superstores; specialty stores, including apparel, electronics, accessories and footwear stores; and home improvement and home furnishings stores. In total, the product holds 30 securities with about 40% of the stocks in the portfolio expected to come up with an earnings beat, suggesting solid upside for the ETF. In particular, Best Buy BBY, Dollar Tree (NASDAQ:DLTR) DLTR, Home Depot (NYSE:HD) and Walgreens Boots Alliance (NASDAQ:WBA) WBA, which are among the top 10 holdings and account for 5% share each, have an Earnings ESP of +5.29%, +10.29%, +9.02%, and +1.39%, respectively.

The fund has accumulated just $13.6 million in its asset base and charges 63 bps in fees per year. Average daily volume is paltry at 2,000 shares. The ETF carries a Zacks ETF Rank #2 with a Medium risk outlook (read: Holiday Sales At 6-Year High: Best Consumer ETFs & Stocks).

PowerShares Dynamic Energy Exploration & Production Portfolio PXE

This product follows the Dynamic Energy Exploration & Production Intellidex Index, which thoroughly evaluates companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action and value. It holds 30 stocks in its basket, 40% of which have higher chances of beating estimates this quarter. The four firms — Continental Resources (NYSE:CLR) , ConocoPhillips (NYSE:COP) COP, EOG Resources (NYSE:EOG) and Occidental Petroleum Corp (NYSE:OXY) OXY — have an Earnings ESP of +17%, +3.17%, +16.88% and +18.77%, respectively. EOG has a Zacks Rank #2, while the rest have a Zacks Rank #1.

PXE is an expensive choice in the energy space, with 0.64% in expense ratio. The fund has AUM of $57.4 million and trades in a volume of 11,000 shares a day on average. It has a Zacks ETF Rank #3 with a High risk outlook (read: Energy ETFs & Stocks Soaring to Start 2018).

iShares U.S. Home Construction ETF (WA:ITB)

This fund provides a pure play to 48 home construction stocks by tracking the Dow Jones U.S. Select Home Construction Index. About 38% of the assets in the basket are expected to surprise this quarter with top firm — DR Horton (NYSE:DHI) — having a Zacks Rank #1 and an ESP of +5.90%. DHI accounts for nearly 13% share in the basket. Other firms like Toll Brothers (NYSE:TOL) , Home Depot (NYSE:HD) and Lowes Companies (NYSE:LOW) have an Earnings ESP of +1.35%, +9.02% and +5.16%, respectively, and have a Zacks Rank #3.

The product has amassed $2.7 billion in its asset base and trades in robust volume of more than 2.3 million shares a day on average. It charges 44 bps in annual fees and has a Zacks ETF Rank #2 with a High risk outlook (read: Top-Ranked ETFs & Stocks That Crushed the Market in 2017).

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>

Home Depot, Inc. (The) (HD): Free Stock Analysis Report

Lowe's Companies, Inc. (LOW): Free Stock Analysis Report

Toll Brothers Inc. (TOL): Free Stock Analysis Report

D.R. Horton, Inc. (DHI): Free Stock Analysis Report

ISHARS-US HO CO (ITB): ETF Research Reports

PWRSH-DYN ENRG (PXE): ETF Research Reports

PWRSH-DYN RETL (PMR): ETF Research Reports

VANECK-BIOTECH (BBH): ETF Research Reports

Illumina, Inc. (ILMN): Free Stock Analysis Report

BioMarin Pharmaceutical Inc. (BMRN): Free Stock Analysis Report

Celgene Corporation (CELG): Free Stock Analysis Report

Amgen Inc. (AMGN): Free Stock Analysis Report

Incyte Corporation (INCY): Free Stock Analysis Report

EOG Resources, Inc. (EOG): Free Stock Analysis Report

Continental Resources, Inc. (CLR): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.